Genetic testing for alpha1-antitrypsin deficiency.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 15266208.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The Alpha Coded Testing Study investigated the risks, benefits, and psychological impact of home genetic testing for alpha1-antitrypsin deficiency. In the study, 996 adult individuals requested and returned a home-administered, confidential, fingerstick blood test. Individuals highly rated the benefits of establishing a diagnosis (82%), helping family members (86%), and anticipating peace of mind (79%). 78% of 239 current smokers reported a high likelihood of smoking cessation if diagnosed with AATD. After testing, more than 60% indicated that they would share the results with family and physicians but < 30% would share results with insurance companies. Confidential home testing for genetic disorders requires a comprehensive program of participant support.
Medical subject headings
- Genetic Testing
- alpha 1-Antitrypsin Deficiency